{"pageProps":{"source":{"compiledSource":"var d=Object.defineProperty,p=Object.defineProperties;var u=Object.getOwnPropertyDescriptors;var i=Object.getOwnPropertySymbols;var n=Object.prototype.hasOwnProperty,r=Object.prototype.propertyIsEnumerable;var l=(e,t,o)=>t in e?d(e,t,{enumerable:!0,configurable:!0,writable:!0,value:o}):e[t]=o,s=(e,t)=>{for(var o in t||(t={}))n.call(t,o)&&l(e,o,t[o]);if(i)for(var o of i(t))r.call(t,o)&&l(e,o,t[o]);return e},h=(e,t)=>p(e,u(t));var c=(e,t)=>{var o={};for(var a in e)n.call(e,a)&&t.indexOf(a)<0&&(o[a]=e[a]);if(e!=null&&i)for(var a of i(e))t.indexOf(a)<0&&r.call(e,a)&&(o[a]=e[a]);return o};const makeShortcode=e=>function(o){return console.warn(\"Component \"+e+\" was not imported, exported, or provided by MDXProvider as global scope\"),mdx(\"div\",s({},o))},Alert=makeShortcode(\"Alert\"),layoutProps={},MDXLayout=\"wrapper\";function MDXContent(o){var a=o,{components:e}=a,t=c(a,[\"components\"]);return mdx(MDXLayout,h(s(s({},layoutProps),t),{components:e,mdxType:\"MDXLayout\"}),mdx(\"h1\",null,\"Links to Other Datasets\"),mdx(\"h2\",null,\"PHOSP-COVID\"),mdx(\"p\",null,\"The \",mdx(\"a\",s({parentName:\"p\"},{href:\"https://www.phosp.org/\"}),`Post-hospitalisation COVID-19 study\n(PHOSP-COVID)`),` is collaborating with the\nNational COVID-19 Chest Imaging Database (NCCID). PHOSP-COVID is a\nnational consortium, led by experts at the University Hospitals of\nLeicester NHS Trust under the umbrella of the NIHR Leicester Biomedical\nResearch Centre. It aims to understand and improve long-term health\noutcomes for patients who have been discharged from hospital with\nconfirmed or suspected COVID-19.`),mdx(\"p\",null,`PHOSP-COVID has been set up and funded as a long term research study to\nrecruit 10,000 patients who have been hospitalised with COVID-19. Over\nthe course of a year, clinical assessments will track patients to gain a\ncomprehensive picture of the impact COVID-19 has had on longer term\nhealth outcomes across the UK.`),mdx(\"p\",null,`PHOSP-COVID will be collecting samples and scans for patients from a\nnetwork of Trusts in the UK (see\n`,mdx(\"a\",s({parentName:\"p\"},{href:\"https://www.phosp.org/network/institution-trust/\"}),\"here\"),` for the full\nlist).`),mdx(\"p\",null,`PHOSP-COVID is collaborating with the NCCID initiative to ensure that\nthe same sites included in the PHOSP-COVID network are also contributing\ntowards the NCCID database. This is so that PHOSP-COVID researchers are\nable to access important data already collected for patients via the\nNCCID study in order to accompany the longitudinal data PHOSP-COVID are\ncollecting for patients.`),mdx(Alert,{title:\"Important information for data collection sites\",mdxType:\"Alert\"},\"If you are contacted by the PHOSP-COVID study to upload data but are not yet contributing to the NCCID, we would ask that you follow the instructions here to ensure you are contributing to both studies.\"),mdx(\"h2\",null,\"ISARIC\"),mdx(\"p\",null,\"The \",mdx(\"a\",s({parentName:\"p\"},{href:\"https://isaric.org/\"}),`International Severe Acute Respiratory and emerging Infection\nConsortium`),` (ISARIC) was founded in 2011 to prevent\nillness and deaths from infectious disease outbreaks. It is a global\nfederation of clinical research networks, providing a proficient,\ncoordinated and agile research response to outbreak-prone infectious\ndisease.`),mdx(\"p\",null,`This consortium is responding to the current COVID-19 outbreak by\ncreating tools for investigators to collect and store data in a\nstandardised way and has supported clinical trials of treatments. One of\nthese tools, the 'Clinical Characterisation Protocol' (CCP), has been\nco-developed by HDR UK members, in consultation with colleagues at the\nWorld Health Organisation.`),mdx(\"p\",null,`The CCP sets out how data and biological samples from patients with\nCOVID-19 should be collected, regardless of where in the world they are.\nIt's the product of many years of discussion among international\ninvestigators from a wide range of scientific and medical disciplines.\nWork to develop this protocol started in response to Middle Eastern\nRespiratory Syndrome coronavirus (MERS-CoV) in 2012-2013, Influenza H7N9\nin 2013, viral haemorrhagic fever (Ebolavirus) in 2014, Monkeypox &\nMERS-CoV in 2018 and Tick-borne encephalitis virus (TBEV) in 2019. It is\nnow being used for COVID-19 .`),mdx(\"p\",null,`ISARIC-4C will augment the aforementioned datasets, which have played a\ncentral role in the UK's research response to COVID-19, with imaging\ndata from the NCCID. This will support improvements in the\nunderstanding, diagnosis and prognosis of the disease through the\navailability of data that comprises a wide range of variables such as\nclinical measurements, 'omics' assays, and radiology scans.`))}MDXContent.isMDXComponent=!0;\n","scope":{"title":"Links to Other Datasets","summary":"The Post-hospitalisation COVID-19 study (PHOSP-COVID) is collaborating with the National COVID-19 Chest Imaging Database (NCCID). PHOSP-COVID is a national consortium, led by experts at the University Hospitals of Leicester NHS Trust under the umbrella of the NIHR Leicester Biomedical Research Centre.","category":"Other Information"}},"meta":{"title":"Links to Other Datasets","summary":"The Post-hospitalisation COVID-19 study (PHOSP-COVID) is collaborating with the National COVID-19 Chest Imaging Database (NCCID). PHOSP-COVID is a national consortium, led by experts at the University Hospitals of Leicester NHS Trust under the umbrella of the NIHR Leicester Biomedical Research Centre.","category":"Other Information"}},"__N_SSG":true}